CVS says the decision to cover Wegovy and exclude Zepbound is 'forcing the drug manufacturers to compete with one another' and will encourage both Eli Lilly and Novo Nordisk to lower prices for their products in the U.S.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
